GBT440

Idiopathic Pulmonary Fibrosis

Clinical trials

Developer

Global Blood Therapeutics

Overview

GBT440 is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 2 tracked IPF clinical trials.

GBT440 clinical trials

NCT02846324 (Phase 2)NCT02989168 (Phase 2)

Explore related

All trials Research

Medical disclaimer. This page summarizes research about GBT440 for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.